首页> 美国卫生研究院文献>Oncotarget >A20 enhances the radiosensitivity of hepatocellular carcinoma cells to 60Co-γ ionizing radiation
【2h】

A20 enhances the radiosensitivity of hepatocellular carcinoma cells to 60Co-γ ionizing radiation

机译:A20增强肝癌细胞对60Co-γ电离辐射的放射敏感性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The radioresistance of hepatocellular carcinoma (HCC) cells is a critical obstacle for effectively applying radiotherapy (RT) in HCC treatment. NF-κB, an important transcription factor, can influence critical cell fate decisions by promoting cell survival or anti-apoptosis in response to cell-stress, e.g. chemotherapies or ionizing radiation (IR). A20, also named as tumor necrosis factor α induced protein 3 (TNFAIP3), is a dominant negative regulator of NF-κB pathway and its functions in HCC are largely unknown. The present work aimed to reveal the role of A20 plays in affecting the radiosensitivity of HCC cells. Higher expression of A20 was detected in hepatic non-tumor cell line or clinical specimens compared with HCC cell lines or clinical specimens. A20 decreased the expression of proteins mediating cellular stress/injury response or epithelial-mesenchymal transition (EMT) process. Overexpression of A20 via adenovirus enhanced the effect of 60Co-γ ionizing radiation (IR) on HCC cells’ injury, e.g. G2/M arrest or DNA double strands break (DSB). Moreover, A20 also enhanced the in vitro or in vivo survival inhibiting of HCC cells induced by IR. These results reveal the roles of A20 in HCC radiosensitization and overexpression of A20 would be a novel strategy for HCC radiotherapy.
机译:肝细胞癌(HCC)细胞的放射抵抗力是在HCC治疗中有效应用放射疗法(RT)的关键障碍。 NF-κB是一种重要的转录因子,可通过促进细胞存活或抗细胞凋亡(例如抗应激)而影响关键的细胞命运决定。化学疗法或电离辐射(IR)。 A20,也称为肿瘤坏死因子α诱导蛋白3(TNFAIP3),是NF-κB通路的主要负调节剂,其在肝癌中的功能尚不清楚。本工作旨在揭示A20在影响HCC细胞放射敏感性中的作用。与HCC细胞系或临床标本相比,在肝非肿瘤细胞系或临床标本中检测到更高的A20表达。 A20降低介导细胞应激/损伤反应或上皮-间质转化(EMT)过程的蛋白质表达。腺病毒使A20过表达增强了 60 Co-γ电离辐射(IR)对HCC细胞损伤的影响,例如G2 / M阻滞或DNA双链断裂(DSB)。此外,A20还增强了IR诱导的HCC细胞的体外或体内存活抑制。这些结果表明,A20在HCC放射增敏中的作用和A20的过表达将是HCC放射治疗的新策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号